Skip to content

Drug interactions

Ambrisentan + Sofosbuvir-velpatasvir

Severity: Minor

Ambrisentan and Sofosbuvir-velpatasvir: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Velpatasvir inhibits OATP transporters, which contribute to ambrisentan hepatic uptake. Ambrisentan exposure may rise modestly, increasing dose-related adverse effects such as edema, headache and anemia.

What this interaction means in plain words

Ambrisentan and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ambrisentan belongs to Miscellaneous; Sofosbuvir-velpatasvir belongs to Anti Virals.

Evidence level: Low

Why it happens

Velpatasvir inhibits OATP1B1, OATP1B3 and OATP2B1, reducing hepatic uptake of ambrisentan.

What to do

No empiric dose change is required; monitor for peripheral edema and hemoglobin changes.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ambrisentan and Sofosbuvir-velpatasvir, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Ambrisentan with Sofosbuvir-velpatasvir?

MediHelp rates the interaction as minor. Ambrisentan and Sofosbuvir-velpatasvir have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Velpatasvir inhibits OATP transporters, which contribute to ambrisentan hepatic uptake. Ambrisentan exposure may rise modestly, increasing dose-related adverse effects such as edema, headache and anemia.

How serious is the interaction between Ambrisentan and Sofosbuvir-velpatasvir?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric dose change is required; monitor for peripheral edema and hemoglobin changes.

What other medicines interact with Sofosbuvir-velpatasvir?

MediHelp also lists interactions of Sofosbuvir-velpatasvir with, for example, Rifampin, Rifapentine, St john's wort. The full list is on the Sofosbuvir-velpatasvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in